MSB 4.89% $1.07 mesoblast limited

News: MSB Mesoblast says qtrly loss attributable $9.8 mln, page-72

  1. 6,264 Posts.
    Your efforts digging up relevant information and providing new perspectives on MSB are refreshing and much appreciated @The Yankee.

    It appears MSB will continue to face headwinds but there is a powerful science engine propelling the blaster forward.

    Without doubt big business seems threatened by how MSB will change the face of medicine and your points below have hit the mark.

    And Mesoblast's business is even more difficult compared to regular pharma, as they are working on a paradigm shift that threatens big LOBBYING and big pharma.
    Last edited by Rappa: 31/05/17
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.14 $1.16 $1.06 $8.816M 8.055M

Buyers (Bids)

No. Vol. Price($)
1 280000 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 2000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.